Ex-Dividend Date: Exponent, Inc. (NASDAQ:EXPO) will trade ex-dividend in 4 days, specifically on September 5th. Investors purchasing shares on or after this date will not be eligible for the upcoming dividend payment.
Dividend Payment: The next dividend payment is set at US$0.30 per share, following a total of US$1.20 paid out last year. This reflects a trailing yield of 1.7% based on the current share price of US$71.38.
Dividend Sustainability
Payout Ratios: Exponent is distributing 58% of its profits as dividends, which is a common level among companies. Additionally, it has paid out 50% of its free cash flow, indicating a comfortable payout level.
Cash Flow vs. Profit: The dividend is supported by both profit and cash flow, suggesting sustainability as long as earnings do not decline significantly.
Earnings Growth and Dividend History
Earnings Performance: Over the past five years, Exponent's earnings per share have grown by 5.4% annually, indicating effective value growth for shareholders. However, the current dividend payout exceeds half of its earnings, which may limit reinvestment in the business and future growth.
Dividend Growth: Over the last decade, Exponent has increased its dividend by approximately 17% per year on average, reflecting a commitment to rewarding shareholders while maintaining earnings growth.
Investment Considerations
Dividend Merits: While Exponent shows some positive indicators, such as a reasonable payout ratio and historical dividend growth, the modest earnings growth and high payout levels raise concerns about future reinvestment and growth potential.
Analyst Insights: Investors are encouraged to consider analyst forecasts and historical performance before making investment decisions regarding Exponent, as the article does not constitute financial advice.
EXPO
$74.2+Infinity%1D
Analyst Views on EXPO
Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Analyst Rating
Wall Street analysts forecast EXPO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for EXPO is 76.00 USD with a low forecast of 76.00 USD and a high forecast of 76.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 74.675
Low
76.00
Averages
76.00
High
76.00
Current: 74.675
Low
76.00
Averages
76.00
High
76.00
UBS
Neutral
maintain
$76 -> $81
2025-12-15
New
Reason
UBS
Price Target
$76 -> $81
2025-12-15
New
maintain
Neutral
Reason
UBS raised the firm's price target on Exponent to $81 from $76 and keeps a Neutral rating on the shares. Recent investor meetings left a positive impression, with management signaling a return to FTE growth that should support a stronger revenue trajectory in 2026, the analyst says in a research note. Improving demand, particularly in Consumer Electronics, and Exponent's premium, highly technical positioning suggest accelerating financial momentum into 2026 despite lingering investor concerns, UBS says.
William Blair
Andrew Nicholas
Market Perform -> Outperform
upgrade
2025-11-17
Reason
William Blair
Andrew Nicholas
Price Target
2025-11-17
upgrade
Market Perform -> Outperform
Reason
William Blair analyst Andrew Nicholas upgraded Exponent to Outperform from Market Perform. The firm believes strength in reactive demand, mid-single-digit headcount growth, and price realization will support the company's return to "at least" high-single-digit revenue growth in 2026. The firm also believes Exponent will be a net beneficiary of artificial intelligence in the medium term. Blair sees an attractive valuation at current levels and likes Exponent's setup over the next 12 months.
Truist
Buy
downgrade
$100 -> $90
2025-11-02
Reason
Truist
Price Target
$100 -> $90
2025-11-02
downgrade
Buy
Reason
Truist lowered the firm's price target on Exponent to $90 from $100 and keeps a Buy rating on the shares. AI could be a beneficiary to engagements for Exponent as clients turn to the company for failure analysis work, but the firm is also acknowledging the risk that efficiencies could lead to less billable hours and believes that automation will remain an overhang on the consulting industry, the analyst tells investors in a research note.
UBS
Neutral
downgrade
$84 -> $76
2025-08-01
Reason
UBS
Price Target
$84 -> $76
2025-08-01
downgrade
Neutral
Reason
UBS lowered the firm's price target on Exponent to $76 from $84 and keeps a Neutral rating on the shares.
About EXPO
Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
